Evidence map›Paper›PMID 36652491›Full record

ArticlePloS one2023

Metabolic and proteomic indications of diabetes progression in human aqueous humor.

Christopher R Fortenbach, Jessica M Skeie, Kristina M Sevcik, A Tim Johnson, Thomas A Oetting, Jaclyn M Haugsdal, Christopher S Sales, Darryl Y Nishimura, Eric B Taylor, Gregory A Schmidt and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Christopher R FortenbachDepartment of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, United States of America.ORCID 0000-0003-2659-8971
Jessica M SkeieDepartment of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, United States of America.
Kristina M SevcikCarver College of Medicine, University of Iowa, Iowa City, IA, United States of America.
A Tim JohnsonDepartment of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, United States of America.
Thomas A OettingDepartment of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, United States of America.
Jaclyn M HaugsdalDepartment of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, United States of America.
Christopher S SalesDepartment of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, United States of America.
Darryl Y NishimuraDepartment of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, United States of America.
Eric B TaylorDepartment of Biochemistry, Fraternal Order of the Eagles Diabetes Research Center, Abboud Cardiovascular Research Center, Holden Comprehensive Cancer Center, and Pappajohn Biomedical Institute, University of Iowa Carver College of Medicine, Iowa City, IA, United States of America.
Gregory A SchmidtIowa Lions Eye Bank, Coralville, IA, United States of America.
Mark A GreinerDepartment of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, United States of America.ORCID 0000-0002-7170-6655
University of Iowa · USMinnesota Lions Eye Bank · US

Funding

Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Alejandro Antonio Pezzulo · 1998 to 2026
$30.5M
Regulation of Hepatic Macronutrient Metabolism by Mitochondrial Citrate TransportR01DK104998 · NIDDK · UNIVERSITY OF IOWA · PI TAYLOR, ERIC B · 2015 to 2022
$3.2M
NIDDK NIH HHS P30 DK054759NIDDK NIH HHS R01 DK104998
6 · The paper itself

Abstract

Diabetes mellitus is a multiorgan systemic disease impacting numerous ocular structures that results in significant ocular morbidity and often results in more frequent corneal and glaucoma surgeries for affected individuals. We hypothesize that the systemic metabolic and proteomic derangement observed in the progression of diabetes influences the composition of the aqueous humor (AH), which ultimately impacts the anterior segment health of the eye. To identify changes associated with diabetes progression, we mapped the metabolite profile and proteome of AH samples from patients with varying severities of type II diabetes (T2DM). Patients were classified as nondiabetic (ND or control), non-insulin-dependent diabetic without advanced features of disease (NAD-ni), insulin-dependent diabetic without advanced features (NAD-i), or diabetic with advanced features (AD). AH samples collected from the anterior chamber during elective ophthalmic surgery were evaluated for metabolite and protein expression changes associated with diabetic severity via gas chromatography/mass spectrometry and ultra-high performance liquid chromatography tandem mass spectrometry, respectively. Metabolic and proteomic pathway analyses were conducted utilizing MetaboAnalyst 4.0 and Ingenuity Pathway Analysis. A total of 14 control, 12 NAD-ni, 4 NAD-I, and 14 AD samples were included for analysis. Elevated levels of several branched amino acids (e.g., valine, leucine, isoleucine), and lipid metabolites (e.g., palmitate) were found only with increasing diabetic severity (i.e., the AD group). Similar proteomic trends were noted in amino acid and fatty acid metabolism and the unfolded protein/stress response. These results represent the first report of both metabolomic and proteomic evaluation of aqueous humor. Diabetes results in metabolic and proteomic perturbations detectable in the AH, and unique changes become manifest as T2DM severity worsens. Changes in AH composition may serve as an indicator of disease severity, risk assessment of anterior segment cells and structures, and potential future therapies.

Indexed as

Aqueous HumorDiabetes Mellitus, Type 2Chromatography, LiquidHumansNADProteomicsNAD

Identifiers

PMID36652491
PMCPMC9847982
OpenAlexW4317360128

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.